These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6493832)

  • 1. Mesothelial proliferation: a questionable boundary with malignancy.
    Quaglia AC
    Pathologica; 1984; 76(1043):387-90. PubMed ID: 6493832
    [No Abstract]   [Full Text] [Related]  

  • 2. [Malignant mesothelioma].
    Pathologica; 1984; 76 Suppl():S81-109. PubMed ID: 6100816
    [No Abstract]   [Full Text] [Related]  

  • 3. Differentiation of serosal hyperplasia and neoplasia in biopsies.
    McCaughey WT; Al-Jabi M
    Pathol Annu; 1986; 21 Pt 1():271-93. PubMed ID: 2417185
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunohistochemical detection of XIAP in mesothelium and mesothelial lesions.
    Wu M; Sun Y; Li G; Desman G; Wang B; Gil J; Burstein DE
    Am J Clin Pathol; 2007 Nov; 128(5):783-7. PubMed ID: 17951200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic appendiceal mucinous adenocarcinoma to well-differentiated diffuse mesothelioma of the peritoneal cavity: a mimicker of florid mesothelial hyperplasia in association with neoplasms.
    Tran TA; Holloway RW; Finkler NJ
    Int J Gynecol Pathol; 2008 Oct; 27(4):526-30. PubMed ID: 18753969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Well-differentiated papillary mesothelioma occurring in the tunica vaginalis of the testis with contralateral atypical mesothelial hyperplasia.
    Tolhurst SR; Lotan T; Rapp DE; Lyon MB; Orvieto MA; Gerber GS; Sokoloff MH
    Urol Oncol; 2006; 24(1):36-9. PubMed ID: 16414491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis.
    Cury PM; Butcher DN; Corrin B; Nicholson AG
    J Pathol; 1999 Oct; 189(2):251-7. PubMed ID: 10547583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytopathology of serous neoplasia of the ovary and the peritoneum: differential diagnosis from mesothelial proliferations.
    Pisharodi LR; Bedrossian CW
    Diagn Cytopathol; 1996 Nov; 15(4):292-5. PubMed ID: 8982583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unusual cytologic presentation of mesothelioma in serous effusions.
    Spriggs AI; Grunze H
    Acta Cytol; 1983; 27(3):288-92. PubMed ID: 6575546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long microvilli of mesothelioma are conspicuous in pleural effusions processed by Ultrafast Papanicolaou stain.
    Yang GC
    Cancer; 2003 Feb; 99(1):17-22. PubMed ID: 12589641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytopathologic differential diagnosis of malignant mesothelioma, adenocarcinoma and reactive mesothelial cells: A logistic regression analysis.
    Cakir E; Demirag F; Aydin M; Unsal E
    Diagn Cytopathol; 2009 Jan; 37(1):4-10. PubMed ID: 18973123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretumorous lesions and lung and pleural tumours induced by asbestos in rats, Syrian golden hamsters and Macaca mulatta (rhesus) monkeys.
    Pylev LN
    IARC Sci Publ; 1980; (30):343-55. PubMed ID: 7239654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of AgNOR technique in distinguishing reactive mesothelial hyperplasia, malignant mesothelioma and pulmonary adenocarcinoma.
    Ramesh K; Gahukamble L; al Fituri O
    Cent Afr J Med; 1994 Sep; 40(9):265. PubMed ID: 7834719
    [No Abstract]   [Full Text] [Related]  

  • 14. Collagen production by human mesothelial cells in vitro.
    Harvey W; Amlot PL
    J Pathol; 1983 Mar; 139(3):337-47. PubMed ID: 6834177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of PCNA in differentiating between malignant mesothelioma and mesothelial hyperplasia: prognostic considerations.
    Esposito V; Baldi A; De Luca A; Paciocco G; Gröger A; Sgaramella G; Claudio PP; Giordano GG; Baldi F; Caputi M; Kaiser H; Giordano A
    Anticancer Res; 1997; 17(1B):601-4. PubMed ID: 9066586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thoracoscopic anatomy, significance of pathologic findings in thoracoscopic open lung biopsy, and pleural mesothelioma].
    Kawai T; Watanabe M; Takagi K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Dec; 32 Suppl():142-7. PubMed ID: 7602822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization.
    Afify AM; Stern R; Michael CW
    Diagn Cytopathol; 2005 Mar; 32(3):145-50. PubMed ID: 15690337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesothelial lesions of the paratesticular region.
    Perez-Ordonez B; Srigley JR
    Semin Diagn Pathol; 2000 Nov; 17(4):294-306. PubMed ID: 11202546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Benign mesothelioma and reactive mesothelial proliferation. A pattern approach].
    Nappi O; Boscaino A; Galloro P
    Pathologica; 2003 Oct; 95(5):301-2. PubMed ID: 14989037
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.
    Politi E; Kandaraki C; Apostolopoulou C; Kyritsi T; Koutselini H
    Diagn Cytopathol; 2005 Mar; 32(3):151-5. PubMed ID: 15690338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.